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ABSTRACT
The past decade has witnessed an exponential development in the field of extracellular vesicles.
Sporadic observations have reached a critical level and the scientific community increasingly
recognizes the potential biomedical significance of these subcellular structures present in all
body fluids as significant components of the cellular secretome. The Educational Committee of
the International Society for Extracellular Vesicles prepared two posters (“Basic aspects of extra-
cellular vesicles” and “Clinical aspects of extracellular vesicles”) to provide essential pieces of
information on extracellular vesicles at glance for anyone not familiar with the field.
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Basic and clinical aspects of extracellular
vesicles
Since 2010, the scientific and clinical interest in extracel-
lular vesicles (EVs) is growing exponentially. EVs are
small, lipid membrane enclosed subcellular structures
carrying biomolecules which are released by cells into
their environment [1–3]. The term “EVs” is an umbrella
term for all types of vesicles, including “exosomes” and
“microparticles” or “microvesicles” [4]. This term is
endorsed by the International Society on Extracellular
Vesicles (ISEV; www.isev.org), a global scientific society
founded in 2011), because at present no biochemical or
(bio)physical distinction can be made between types of
EVs generated by different biogenesis pathways [2].
The two posters by ISEV on “Basic aspects of extra-
cellular vesicles” and “Clinical aspects of extracellular
vesicles” provide a brief introduction about EVs to
students and (bio) medical healthcare professionals.
Basic aspects of extracellular vesicles (Figure 1)
All cells release EVs into their environment, and (bio)fluids
such as conditioned culture medium and body fluids
contain EVs. When EVs are visualized by electron micro-
scopy (A and B are EM microphotographs provided by
Rienk Nieuwland and Agnes Kittel, respectively), EVs
appear as small, usually spherical particles surrounded by
a phospholipid bilayer membrane. This membrane often
contains proteins from the parental cell, thus enabling the
identification of the cell of origin. In addition, EVs contain
biomolecules originating from the parental cells, including
RNA and DNA, metabolites and lipids [5].
Initially, EVs were often named after the cell type of
origin, or after the organ in which they were discov-
ered, such as dexosomes or prostasomes. Because this
nomenclature was not only confusing but also resulted
in development of parallel research fields lacking inter-
action, ISEV endorses the term “extracellular vesicles”
as an umbrella term [C http://evpedia.info, 6].
Detailed analysis of the biochemical composition of
EVs has shown that the overall composition of EVs differs
from that of the releasing parental cells. This implies that
cargo sorting mechanisms exits that affect the composition
of EVs. Moreover, the biochemical composition depends
on the “status” (resting, activated, etc.) of the parental cell.
EVs can be released directly by budding from the plasma
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membrane, by secretion of prestored EVs in multi-
vesicular bodies, by formation of apoptotic bodies as well
as released from enveloped virus-infected cells (D). Due to
all these variables, EVs are highly heterogeneous in size
and composition [7–9].
EVs are not merely “innocent bystanders” but play
important roles in physiology and pathology (E). In
physiology, EVs contribute to homeostasis and promote
host-defence mechanisms including haemostasis and
inflammation [3], whereas in pathology EVs may con-
tribute to disease development and progression, for
example in cancer [10,11]. Because EVs are capable of
delivering their proteins, lipid and RNA cargo to target
(recipient) cells, EVs can regulate gene expression and
consequently the phenotype and biological functions of
the target cell. Thus, by exchanging information between
cells, EVs contribute to intercellular communication.
ISEV (F) developed a massive open online course on
EVs that is freely available [Massive Online Open Course
(MOOC) (G), http://coursera.org/learn/extracelllular-
vesicles, 12], published minimal requirements for studies
on EVs [MISEV, 13] (H). ISEV endorses a knowledge base
that has been launched to monitor the quality of pre-
analytical data reporting [http://evtrack.org, 14] (H). The
Extracellular vesicles (EVs) are enclosed by a
phospholipid membrane. EVs originate from
prokaryotes and eukaryotic cells, and most EVs
range in size between 50 nm and 1 m. EVs
consist of lipids, proteins, RNA and DNA, and
occur in body fluids, conditioned cell culture
media, consumables, water, etc.
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EVs are released by plasma membrane budding,
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contributing to cellular homeostasis and
host defence, and by affecting disease
development and progression.
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Figure 1. Basic aspects of extracellular vesicles.
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official journal of ISEV is the Journal of Extracellular
Vesicles (JEV) (I).
Clinical aspects of extracellular vesicles (Figure 2)
In general, EVs have a huge potential for diagnosis of
disease, prognosis and monitoring of therapy [15].
Because EVs can be considered as naturally occurring
autologous nanocarriers”, EVs can be loaded with
drugs for local drug delivery (A).
At present, standard operation procedures are
being developed for routine collection, storage and
handling of biofluids and body fluids such as urine,
blood and breast milk to enable the comparison of
measurements between patients and controls and to
allow exchange of data between institutes and instru-
ments, etc. (B).
In most clinical studies, EV-containing biofluids will
be collected in biorepositories. The pre-analytical con-
ditions may differ between biofluids, but removal of
cells and cell fragments is essential to circumvent con-
tamination due fragmentation of cells during freeze
thawing (C).
Because all human (and animal) body fluids contain
EVs, and because the cellular origin, composition and
functions of EVs change in disease, the detailed analy-
sis of EVs is thought to behold clinically relevant
information. To get access to this information, how-
ever, most downstream applications require either iso-
lation and/or concentration of EVs (D).
Detection of (single) EVs and detailed insight into their
biochemical composition by downstreammethods such as
proteomics requires a thorough understanding of the bio-
chemical and (bio)physical limitations and possibilities of
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Figure 2. Clinical aspects of extracellular vesicles
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the various isolation, detection and characterization meth-
ods (E). In addition, the method of collection, handling
and storage conditions of EV can alter the molecular
composition of EV [16,17].
For more information, please visit the MOOC on
EVs (F), the Journal of Extracellular Vesicles (JEV) (G)
or contact the International Society for Extracellular
Vesicles (H).
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